Patent ID: 6194461
Filing Date: 2001-02-27
Classification: A61K,C07C

Abstract:
A medicament for treating retinal degenerative disorder comprising a compound represented by the figure (1) or a pharmaceutically acceptable salt thereof: ##STR14##wherein Ar is optionally substituted phenyl or optionally substituted heteroaryl;n is 0, 1 or 2;W is --CH.sub.2 NH-- or --CH.dbd.N(O)--;R.sup.1, R.sup.2 and R.sup.3 are independently optionally substituted alkyl, carboxyl or alkoxycarbonyl; any two groups of R.sup.1, R.sup.2 and R.sup.3 may be taken together with the carbon atom to form optionally substituted cycloalkane; all of R.sup.1, R.sup.2 and R.sup.3 may be taken together with the adjacent carbon atom to form optionally substituted bicycloalkane or optionally substituted tricycloalkane;R.sup.4 and R.sup.5 are independently hydrogen atom or optionally substituted alkyl.